OLR1 and atherosclerosis: Moreover, the absence of clinically significant macro- or microvascular atherosclerotic complications in the patients included in the study may be associated with the presence of subclinical atherosclerosis, as suggested by the observed correlation between increased serum sLOX-1 levels and cIMT.